Investigating the levels of depression, anxiety, sexual disorders, and other influencing factors in breast cancer patients: Turkish radiation oncology integrative group study (12-05)

dc.contributor.authorGul, Sule Karabulut
dc.contributor.authorTepetam, Huseyin
dc.contributor.authorGursel, Ozge Kandemir
dc.contributor.authorAlanyali, Senem
dc.contributor.authorOruc, Ahmet Fatih
dc.contributor.authorTugrul, Fuzuli
dc.contributor.authorErgen, Sefika Arzu
dc.date.accessioned2024-02-23T14:21:14Z
dc.date.available2024-02-23T14:21:14Z
dc.date.issued2023
dc.departmentNEÜen_US
dc.description.abstractThe fear of death associated with cancer and the side effects of its treatments can have a detrimental psychological impact on breast cancer patients. Early detection and support services play a crucial role in alleviating the expected symptoms of depression, anxiety, and sexual dysfunction. The objective of our study is to assess the levels of depression, anxiety, and sexual dysfunction in breast cancer patients, as well as identify the factors that influence these conditions. The study involved 329 voluntarily participating breast cancer patients who had undergone surgery and were in the follow-up stage. Data were collected from 8 different centers after obtaining ethical approval. The assessment utilized tools such as the Sociodemographic Information Form, Beck Depression and Anxiety Scale, and Arizona Sexual Experiences Scale. Data analysis was performed using SPSS 20. The study included 329 breast cancer patients in the follow-up stage post-surgery. Their average age was 52.7 years (range: 27-83). Results indicated that 33.1% experienced moderate to severe depression, 18.2% reported severe anxiety, and 82.7% scored above 11 on the sexual scale. Factors linked to higher scores were mastectomy, surgical dissatisfaction, insufficient information on sexual side effects, and comorbidities like smoking and diabetes. The study emphasizes the importance of closely monitoring anxiety, depression levels, and sexual side effects in breast cancer treatment. It underscores the need to focus not only on reducing mortality rates but also on supporting patients' psychological and sexual well-being, ultimately improving their overall quality of life.en_US
dc.identifier.doi10.1097/MD.0000000000035280
dc.identifier.issn0025-7974
dc.identifier.issn1536-5964
dc.identifier.issue45en_US
dc.identifier.pmid37960771en_US
dc.identifier.scopus2-s2.0-85176897247en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1097/MD.0000000000035280
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13508
dc.identifier.volume102en_US
dc.identifier.wosWOS:001103423000020en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofMedicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAsexen_US
dc.subjectBdien_US
dc.subjectMastectomyen_US
dc.subjectSexual Healthen_US
dc.subjectSociodemographicen_US
dc.titleInvestigating the levels of depression, anxiety, sexual disorders, and other influencing factors in breast cancer patients: Turkish radiation oncology integrative group study (12-05)en_US
dc.typeArticleen_US

Dosyalar